Abstract
Rett syndrome (RTT) is an X-linked neurodevelopmental disorder caused by mutations in the MECP2 gene. In 49 female RTT children, aged 1.9–17 y, bone mass was assessed and correlated with clinical parameters and mutations involving the MECP2 gene. We also studied five adult females, aged 20–33 y, and one male child, aged 6 y. Lumbar spine bone mineral content (BMC) and bone mineral density (BMD) were correlated with weight, height, BMI, clinical severity, degree of scoliosis, use of anticonvulsants, and ambulatory status. L1-L4 BMD and BMC showed that 48.9% of them had BMD values >2 SD below age-related norms. BMD values were in the osteoporotic range in the five adult females with RTT. Eleven percent of the children and adults with RTT experienced fractures. Low bone mass was correlated with marginal significance to clinical severity and ambulation but not to scoliosis or anticonvulsant use. Lowest bone mass occurred in patients with T158M or R270X mutations but without statistical significance. Studies in a murine model of RTT confirmed low bone mass as an inherent component of this syndrome. MECP2 mutations and clinical parameters impact bone mass in RTT, but an association with a specific mutation was not demonstrable.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- BMC:
-
bone mineral content
- BMD:
-
bone mineral density
- CV:
-
coefficient of variation
- DXA:
-
dual energy absorptiometer
- MECP2 :
-
methyl-CpG-binding protein 2
- RTT:
-
Rett syndrome
- RSSS:
-
Rett Syndrome Severity Scale
References
Kozinetz CA, Skender ML, MacNaughton N, Almes MJ, Schultz RJ, Percy AK, Glaze DG 1993 Epidemiology of Rett syndrome: a population-based registry. Pediatrics 91: 445–450
Bird A 2008 The methyl-CpG binding protein MeCP2 and neurological disease. Biochem Soc Trans 36: 575–583
RettBASE IRSF MECP2 Variation Database. Available at: http://mecp2.chw.edu.au. Accessed June 9, 2010
Guy J, Hendrich B, Holmes M, Martin JE, Bird A 2001 A mouse MeCP2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27: 322–326
Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY 1999 Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185–188
Hagberg B, Hanefeld F, Percy A, Skjeldal O 2002 An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden, Germany, 11 September 2001. Eur J Pediatr Neurol 6: 293–297
Trevathan E, Naidu S 1988 The clinical recognition and differential diagnosis of Rett syndrome. J Child Neurol 3: S6–S16
Leonard H, Thomson M, Bower C, Fyfe S, Constantinou J 1995 Skeletal abnormalities in Rett syndrome: increasing evidence for dysmorphogenetic defects. Am J Med Genet 58: 282–285
Hoffbuhr KC, Moses LM, Jerdonek MA, Sirianni N, Scacheri C, Giron J, Schuette J, Innis J, Marino M, Philippart M, Narayanan V, Umansky R, Kronn D, Hoffman EP, Naidu S 2002 Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. Ment Retard Dev Disabil Res Rev 8: 99–105
Baim S, Leonard M, Bianchi ML, Hans DB, Kalkwarf H, Langman C, Rauch F 2008 Official positions of the international Society for clinical Densitometry and Executive summary of the 2008 ISCD Pediatric Position Development Conference. J Clin Densitom 11: 6–21
Kalkwarf HJ, Zemel BS, Gilsanz V, Lappe JM, Horlick M, Oberfield S, Mahboubi S, Fan B, Frederick MM, Winer K, Shepherd JA 2007 The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 92: 2087–2099
Schwartzman F, Vitolo MR, Schwartzman JS, Morais MB 2008 [Eating practices, nutritional status and constipation in patients with Rett syndrome]. Arq Gastroenterol 45: 284–289
Tan KJ, Moe MM, Vaithinathan R, Wong HK 2009 Curve progression in idiopathic scoliosis: follow-up study to skeletal maturity. Spine 34: 697–700
Chou IJ, Lin KL, Wang HS, Wang CJ 2007 Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy. Acta Paediatr Taiwan 48: 317–322
Leonard H, Thomson M, Glasson E, Fyfe S, Leonard S, Ellaway C, Christodoulou J, Bower C 1999 Metacarpophalangeal pattern profile and bone age in Rett syndrome: further radiological clues to the diagnosis. Am J Med Genet 83: 88–95
Haas RH, Dixon SD, Sartoris DJ, Hennessy MJ 1997 Osteopenia in Rett syndrome. J Pediatr 131: 771–774
Motil KJ, Ellis KJ, Barrish JO, Caeg E, Glaze DG 2008 Bone mineral content and bone mineral density are lower in older than in younger females with Rett syndrome. Pediatr Res 64: 435–439
Loder RT, Lee CL, Richards BS 1989 Orthopedic aspects of Rett syndrome: a multicenter review. J Pediatr Orthop 9: 557–562
Downs J, Bebbington A, Woodhead H, Jacoby P, Jian L, Jefferson A, Leonard H 2008 Early determinants of fractures in Rett syndrome. Pediatrics 121: 540–546
Ager S, Fyfe S, Christodoulou J, Jacoby P, Schmitt L, Leonard H 2006 Predictors of Scoliosis in Rett Syndrome. J Child Neurol 21: 809–813
Lee WT, Cheung CS, Tse YK, Guo X, Qin L, Lam TP, Ng BK, Cheng JC 2005 Association of osteopenia with curve severity in adolescent idiopathic scoliosis: a study of 919 girls. Osteoporos Int 16: 1924–1932
Gissel T, Poulson CS, Vestergaard P 2007 Adverse effects of antiepileptic drugs on bone mineral density in children. Expert Opin Drug Saf 6( 3): 267–278
Gissel T, Poulson CS, Vestergaard P 2007 Adverse effects of epileptic drugs on bone mineral density in children. Expert Opin Drug Saf 6: 267–278
Nettekoven S, Strohle A, Trunz B, Wolters M, Hoffmann S, Horn R, Steinert M, Brabant G, Lichtinghagen R, Welkoborsky HJ, Tuxhorn I, Hahn A 2008 Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy. Eur J Pediatr 167: 1369–1377
Budden SS, Gunness ME 2003 Possible mechanisms of osteopenia in Rett syndrome: bone histomorphometric studies. J Child Neurol 18: 698–702
O'Connor RD, Zayzafoon M, Farach-Carson MC, Schanen NC 2009 MeCP2 deficinecy decreases bone formation and reduces bone volume in a rodent model of Rett syndrome. Bone 45: 346–356
Archer H, Evans J, Leonard H, Colvin L, Ravine D, Christodoulou J, Williamson S, Charman T, Bailey M, Sampson J, Klerk N, Clarke A 2007 Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation. J Med Genet 44: 148–152
Allison SJ, Baldock PA, Herzog H 2007 The control of bone remodeling by neuropeptide Y receptors. Peptides 28: 320–325
Elefteriou F 2008 Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys 473: 231–236
Chadwick LH, Wade PA 2007 MeCP2 in Rett syndrome: transcriptional repressor or chromatin architectural protein?. Curr Opin Genet Dev 17: 121–125
Johnston MV, Blue ME, Naidu S 2005 Rett syndrome and neuronal development. J Child Neurol 20: 759–763
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was funded by grants from NICHD PO1-24448, and the Institute for Clinical and Translational Research, grants UL1RR025005 and FD-R-002408 [to S.N.].
Rights and permissions
About this article
Cite this article
Shapiro, J., Bibat, G., Hiremath, G. et al. Bone Mass in Rett Syndrome: Association With Clinical Parameters and MECP2 Mutations. Pediatr Res 68, 446–451 (2010). https://doi.org/10.1203/PDR.0b013e3181f2edd2
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/PDR.0b013e3181f2edd2
This article is cited by
-
MiR-422a promotes adipogenesis via MeCP2 downregulation in human bone marrow mesenchymal stem cells
Cellular and Molecular Life Sciences (2023)
-
Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome
BMC Medical Genetics (2020)
